It has been reported that adiponectin modifies the association between resistin and mortality in ESKD patients [38], whereas in another prospective study from our group, we reported a mutual effect modification between adiponectin and HDL cholesterol as risk factors for CV events in T2DM patients [15]. Here, ADIPOQ is linked to type 2 diabetes mellitus.